Sema4 Holdings Corp
NASDAQ:SMFR
Relative Value
There is not enough data to reliably calculate the relative value of SMFR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
SMFR Competitors Multiples
Sema4 Holdings Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
S
|
Sema4 Holdings Corp
NASDAQ:SMFR
|
132.7m USD | 0.6 | -0.2 | -0 | -0 | |
US |
Cigna Corp
NYSE:CI
|
106.7B USD | 0.5 | 20.7 | 10.6 | 14.1 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
98B EUR | 0.5 | 20.5 | 10.5 | 14 | |
US |
CVS Health Corp
NYSE:CVS
|
102.2B USD | 0.3 | 12.3 | 9.9 | 9.9 | ||
DE |
F
|
Fresenius Medical Care AG
XMUN:FME
|
20.8B EUR | 1.1 | 41.7 | 10.1 | 24.8 | |
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
18.1B USD | 1.5 | 43.4 | 12.8 | 19.4 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
14.1B EUR | 0.6 | -23.8 | 9.5 | 21.2 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
14.7B USD | 1.6 | 17.3 | 10.5 | 14 | ||
US |
DaVita Inc
NYSE:DVA
|
12.2B USD | 1 | 17.7 | 8.6 | 12.6 | ||
MY |
H
|
Hong Seng Consolidated Bhd
KLSE:HONGSENG
|
56.1B MYR | 3 672.6 | -1 661.7 | -1 608.1 | -1 608.1 | |
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.5B EUR | 0.5 | 21.1 | 6.7 | 16.5 |